| Jan'20 | Oct'19 | Jul'19 | Apr'19 | Jan'19 | Oct'18 | Jul'18 | Apr'18 | Jan'18 | Oct'17 | Jul'17 | Apr'17 | Jan'17 | Oct'16 | Jul'16 | Apr'16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating activities: | |||||||||||||||
Net loss | |||||||||||||||
-30,577 | -42,717 | -29,291 | -18,959 | -15,460 | -22,940 | -19,396 | -17,041 | -16,998 | -17,062 | -16,399 | -16,106 | -14,573 | -10,222 | -9,012 | -9,343 |
Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||||||||||||
Depreciation and amortization | |||||||||||||||
2,233 | 2,014 | 1,881 | 1,941 | 1,785 | 1,787 | 1,665 | 1,576 | 1,372 | 1,366 | 1,209 | 1,176 | 1,133 | 1,000 | 981 | 968 |
Provision for bad debts | |||||||||||||||
949 | 278 | -21 | 40 | 190 | -51 | 277 | 76 | 157 | 152 | 90 | 79 | 331 | 132 | 169 | 21 |
Stock-based compensation expense | |||||||||||||||
16,853 | 21,092 | 16,609 | 13,216 | 12,290 | 12,922 | 11,028 | 7,993 | 7,358 | 5,937 | 5,003 | 4,062 | 3,535 | 2,517 | 2,201 | 1,598 |
Change in fair value of convertible preferred stock warrant liability | |||||||||||||||
- | - | - | - | - | - | - | - | 0 | 0 | 0 | 491 | 147 | 64 | -2 | 44 |
Deferred income taxes | |||||||||||||||
- | 0 | -61 | 3 | - | 3 | -35 | -22 | - | -19 | 19 | -13 | 36 | 8 | -6 | -7 |
Amortization of deferred financing costs | |||||||||||||||
- | 70 | 70 | 47 | - | 32 | 32 | 34 | - | 36 | 35 | 34 | 104 | -36 | 36 | 0 |
Amortization of (discount) premium on marketable securities | |||||||||||||||
- | 7 | 47 | 82 | - | 108 | -8 | -39 | - | -64 | -44 | 0 | - | - | - | - |
Amortization of operating lease right-of-use assets | |||||||||||||||
3,085 | 3,329 | 3,132 | 1,578 | - | - | - | - | - | - | - | - | - | - | - | - |
Changes in operating assets and liabilities: | |||||||||||||||
Restricted cash | |||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | -5,789 |
Accounts receivable | |||||||||||||||
42,889 | 2,019 | 4,268 | -22,195 | 22,587 | 5,503 | 3,804 | -20,293 | 20,665 | 9,539 | -4,631 | -8,537 | 11,609 | 4,977 | -1,994 | -10,475 |
Prepaid expenses and other current assets | |||||||||||||||
620 | -816 | -12 | -60 | 3,420 | -365 | 3,311 | 379 | 2,054 | -582 | 1,294 | 1,277 | -514 | 230 | 863 | 1,063 |
Costs to obtain revenue contracts | |||||||||||||||
12,148 | 3,633 | 2,198 | 365 | 9,957 | 2,201 | 3,823 | 836 | 3,268 | 665 | 122 | 365 | 3,066 | 1,959 | 143 | 405 |
Other long term assets | |||||||||||||||
948 | 623 | -855 | 1,913 | -511 | 415 | 15 | 79 | 197 | 42 | -101 | 220 | 25 | -49 | 452 | 2 |
Accounts payable, accrued expenses and other current liabilities | |||||||||||||||
5,106 | 3,722 | 5,777 | -6,338 | 13,297 | -1,377 | 8,780 | -3,074 | 3,320 | 881 | 1,488 | -4,994 | 5,318 | 2,323 | 1,037 | -2,641 |
Unearned revenue | |||||||||||||||
69,876 | -15,326 | -2,497 | -9,708 | 53,989 | -4,588 | 4,511 | -6,908 | 29,490 | 2,138 | -118 | 243 | 17,400 | 2,372 | -1,052 | 2,222 |
Operating lease liabilities | |||||||||||||||
532 | 823 | -1,157 | -1,242 | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred rent | |||||||||||||||
- | - | - | - | - | - | - | - | - | 278 | 310 | -7 | 153 | 74 | 149 | 214 |
Other long term liabilities | |||||||||||||||
87 | 364 | -232 | 346 | 248 | -490 | -342 | -263 | -1,142 | 69 | 18 | 2 | 3 | 2 | 3 | 9 |
Net cash (used in) provided by operating activities | |||||||||||||||
11,666 | -31,817 | -11,436 | 819 | 30,820 | -22,564 | -4,425 | 1,409 | -2,079 | -16,381 | -5,605 | -8,344 | -6,694 | -9,031 | -5,258 | 7,451 |
Investing activities: | |||||||||||||||
Maturities of marketable securities | |||||||||||||||
0 | 5,400 | 21,100 | 24,697 | 27,900 | 27,353 | 17,844 | 13,223 | 12,654 | 7,500 | 0 | 0 | - | - | - | - |
Capital expenditures | |||||||||||||||
4,542 | 2,898 | 3,618 | 831 | 949 | 1,618 | 1,131 | 1,572 | 927 | 861 | 808 | 1,078 | 607 | 1,261 | 808 | 829 |
Net cash provided by (used in) investing activities | |||||||||||||||
-4,542 | 2,502 | 17,482 | 23,866 | 26,951 | -2,489 | -7,979 | 11,651 | 7,238 | 971 | -95,254 | -1,078 | -607 | -1,261 | -1,106 | -829 |
Financing activities: | |||||||||||||||
Proceeds from initial public offering, net of underwriting discounts and commissions | |||||||||||||||
- | - | - | - | - | - | - | - | 0 | 0 | 0 | 123,527 | 0 | 0 | 0 | 0 |
Proceeds from common stock offering, net of underwriting discounts and commissions | |||||||||||||||
0 | 0 | 0 | 147,000 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
Payments of deferred offering costs | |||||||||||||||
0 | 0 | 322 | 208 | 0 | 0 | 0 | 0 | 0 | 0 | 2,294 | 1,969 | 170 | 0 | 0 | 0 |
Proceeds from exercise of stock options | |||||||||||||||
2,380 | 3,346 | 4,167 | 5,000 | 3,836 | 4,879 | 5,217 | 4,948 | 6,924 | 2,305 | 241 | 2,140 | 474 | 156 | 205 | 486 |
Repayments on Revolving Line | |||||||||||||||
- | - | - | - | - | - | - | - | 0 | 0 | 0 | 5,000 | 0 | 0 | 0 | 0 |
Payments of deferred financing costs | |||||||||||||||
0 | 0 | 97 | 163 | 0 | 0 | 159 | 0 | - | - | - | - | 183 | -180 | 95 | 85 |
Proceeds, net from employee stock purchase plan withholdings | |||||||||||||||
2,192 | 1,431 | 1,779 | 1,868 | 1,716 | 1,468 | 1,258 | 1,221 | 1,026 | 1,387 | 1,337 | 0 | - | - | - | - |
Net cash provided by financing activities | |||||||||||||||
4,572 | 4,777 | 5,527 | 153,497 | 5,552 | 6,347 | 6,316 | 6,169 | 7,950 | 3,692 | -736 | 118,698 | 5,121 | 336 | 110 | 401 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||||||||||||
-374 | 491 | -435 | -174 | 95 | -112 | -160 | -193 | 146 | -49 | 237 | 41 | 83 | -24 | -93 | 4 |
Net increase in cash, cash equivalents and restricted cash | |||||||||||||||
11,322 | -24,047 | 11,138 | 178,008 | 63,418 | -18,818 | -6,248 | 19,036 | 13,255 | -11,767 | -101,358 | 109,317 | -2,097 | -9,980 | -6,347 | 7,027 |
Supplemental disclosures of non-cash investing and financing activities: | |||||||||||||||
Cash paid on interest | |||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | -180 | 183 | 0 | 0 |
Conversion of convertible preferred stock warrants to common stock warrants | |||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 |
Cash paid on income taxes | |||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 15 | -2 | 6 | 0 |
Non-cash capital expenditures in accounts payable, accrued expenses and other current liabilities | |||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 8 | -24 | -10 | 138 |
Deferred offering costs in accounts payable, accrued expenses and other current liabilities | |||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
Common stock issued for the acquisition of Inner Balloons | |||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 |